Requirement of vitamin D supplementation in patients with systemic lupus erythematosus;Potrzeba suplementacji witaminy D u chorych na toczeń rumieniowaty układowy

Reumatologia

Volumn 46, Issue 4, 2008, Pages 223-229

  Bogaczewicz, Jarosław ^a,d   Sysa Jȩdrzejowska, Anna ^a   Arkuszewska, Cecylia ^a   Hawro, Tomasz ^a   Za̧bek, Jakub ^b   Karczmarewicz, Elzbieta ^c   Lorenc, Roman S ^c   Płudowski, Paweł ^c   Woźniacka, Anna ^a  

^a Katedra I Klinika Dermatologii I Wenerologii Uniwersytetu Medycznego W Odzi   (Poland)

^b Im Prof dr Hab Med Eleonory Reicher W Warszawie

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Calcidiol; Cholecalciferol; Systemic lupus erythematosus; Vitamin D

Indexed keywords

EID: 54949120666     PISSN: 00346233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sysa-Jȩdrzejowska A. Choroby tkanki ła̧cznej. W: Immunologia kliniczna. Kowalski M (red.). Oficyna Wydawnicza Mediton, Łódź 2000; 341-357.
2. Lin JH, Dutz JP, Sontheimer RD, Werth VP. Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol 2007; 33: 85-106.
3. Matsuoka LY, Ide L, Wortsman J, et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987; 64: 1165-1168.
4. Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol 2006; 54: 301-317.
5. Redlich K, Ziegler S, Kiener HP, et al. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis 2000; 59: 308-310.
6. Boyanov M, Robeva R, Popivanov P. Bone mineral density changes in women with systemic lupus erythematosus. Clin Rheumatol 2003; 22: 318-323.
7. O Di Munno O, Mazzantini M, Delle Sedie A, et al. Risk factors for osteoporosis in female patients with systemic lupus erythematosus. Lupus 2004; 13: 724-730.
8. Cunnane G, Lane NE. Steroid-induced osteoporosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2000; 26: 311-329.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
10. Liang MH, Socher SA, Larson MG, et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.
11. Lorenc RS, Głuszko P, Karczmarewicz E, et al. Zalecenia postȩpowania diagnostycznego i leczniczego w osteoporozie. Obniżenie czȩstości złamań poprzez efektywna̧ profilaktykȩ i leczenie. Terapia 2007; 9: 9-39.
12. Tian XQ, Chen TC, Matsuoka LY, et al. Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem 1993; 268: 14888-14892.
13. Holick MF. Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed Proc 1987; 46: 1876-1882.
14. Wolska H. Fototerapia w dermatologii. Wydawnictwo Czelej, Lublin 2006; 3-15.
15. Holick MF. Sunlight "D"ilemma: risk of skin cancer or bone disease and muscle weakness. Lancet 2001; 357: 4-6.
16. O'Regan S, Chesney RW, Hamstra A, et al. Reduced serum 14,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 1979; 68: 109-111.
17. Müller K, Kriegbaum NJ, Baslund B, et al. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995; 14: 397-400.
18. Huisman AM, White KP, Algra A, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia J Rheumatol 2001; 28: 2535-2539.
19. Kamen DL, Cooper GS, Bouali H, et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5: 114-117.
20. Carvalho JF, Blank M, Kiss E, et al. Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci 2007; 1109: 550-557.
21. Orbach H, Zandman-Goddard G, Amital H, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 2007; 1109: 385-400.
22. Adams JS, Diz MM, Sharma OP. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 1989; 111: 437-438.
23. Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 2002; 8: 174-179.
24. 3 synthesis in human skin. J Clin Endocrinol Metab 1988; 67: 373-378.
25. Sen D, Keen RW. Osteoporosis in systemic lupus erythematosus: prevention and treatment. Lupus 2001; 10: 227-232.
26. British Medical Association and Royal Pharmaceutical Society of Great Britain: Nutrition and blood. British National Formulary 2007; 54: 483-526.
27. Matsukawa Y, Ikeda E, Hayama T, et al. Ectopic calcinosis possibly due to 1 alpha (OH) vitamin D3 in a patient with systemic lupus erythematosus. Clin Exp Rheumatol 1995; 13: 91-94.
28. Miyata M, Kurokawa M, Watanabe S, et al. Periarticular ectopic calcinosis probably due to 1 alpha-OH-vitamin D3 therapy, and successful treatment with bisphosphonate compound in a patient with systemic lupus erythematosus. Fukushima J Med Sci 1996; 42: 39-46.
29. Sugimoto H, Hyodoh K, Kikuno M, et al. Periarticular calcification in systemic lupus erythematosus. J Rheumatol 1999; 26: 574-579.
30. Okada J, Nomura M, Shirataka M, et al. Prevalence of soft tissue calcifications in patients with SLE and effects of alfacalcidol. Lupus 1999; 8: 456-461.